Apotex
FL · 12 filings, 2025
What the money shows
Apotex reported $1.7M in federal lobbying for 2025 across 12 filings. The filings name 3 lobbying firms, led by Ballard Partners and Kountoupes Denham CARR & REID. The filing text lists 3 issue areas.
Sources: Senate LDA · FEC
Apotex Inc. is a Canadian pharmaceutical corporation. Founded in 1974 by Barry Sherman, the company is the largest producer of generic drugs in Canada, with annual sales exceeding CA$2.5 billion. By 2023, Apotex employed close to 8,000 people as Canada's largest drug manufacturer, with over 300 products selling in over 115 countries. Apotex manufactures and distributes generic medications for a range of diseases and health conditions that include cancer, diabetes, high cholesterol, glaucoma, infections and blood pressure. via Wikipedia ↗
1Lobbies on
Its filings list: Manufacturing · Health Issues · Tariff (miscellaneous tariff bills)
2Through these firms · 3
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- HR 10033Rules for self-driving cars and emergency crews